What is the drug class of Keflex (cephalexin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) Drug Class

Keflex (cephalexin) is a first-generation cephalosporin antibiotic, which belongs to the broader beta-lactam antibiotic class. 1

Chemical Structure and Classification

Cephalexin is a semisynthetic cephalosporin antibiotic with the chemical structure 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid, monohydrate. Its molecular structure is related to other cephalosporin antibiotics, with key differences:

  • Contains a D-phenylglycyl group at the 7-amino position
  • Has an unsubstituted methyl group at the 3-position
  • The cephalosporins differ from penicillins in the structure of their bicyclic ring system 1

Antimicrobial Spectrum

As a first-generation cephalosporin, cephalexin has:

  • Excellent gram-positive coverage
  • Limited gram-negative coverage 2
  • Particularly effective against:
    • Streptococci (including beta-hemolytic streptococci)
    • Staphylococci (methicillin-susceptible)
    • Some common gram-negative organisms 3

Clinical Applications

Cephalexin is commonly used for:

  • Skin and soft tissue infections (first-line therapy) 4, 5
  • Upper respiratory tract infections 6
  • Urinary tract infections 7
  • Mild diabetic foot infections without complicating factors 4

Pharmacokinetic Properties

  • Absorption: Not absorbed from the stomach but totally and rapidly absorbed in the upper intestine
  • Distribution: Rapidly distributed to tissues (except spinal fluid and aqueous humor)
  • Metabolism: No measurable destruction or metabolism in the body
  • Excretion: Rapidly cleared by the kidneys with 70-100% of the dose found in urine 6-8 hours after administration
  • Dosage adjustment: Required in patients with creatinine clearance less than 30 ml/min 3, 8

Cross-Reactivity Considerations

Important considerations regarding cross-reactivity with penicillin allergies:

  • Cephalexin shares an R1 side chain with amoxicillin and ampicillin, potentially increasing cross-reactivity risk in patients with penicillin allergies 4
  • For patients with a history of anaphylaxis, angioedema, or urticaria with penicillins, cephalexin should not be administered due to possible cross-reactions 4
  • Cross-reactivity between penicillins and cephalosporins was previously estimated at around 10%, but more recent data suggests it may be lower (2-4.8%) for newer cephalosporins 4

Resistance Patterns

  • Resistance rates to cephalexin among viridans group streptococci can be high (reported at 96% in one study)
  • First-generation cephalosporins generally have higher resistance rates compared to later generations 4

Dosing Considerations

  • Adults: Typically 250-500 mg orally every 6 hours
  • Children: May require higher doses per kilogram than adults due to greater body water turnover 3
  • Renal impairment: Dose reduction proportional to reduced kidney function 3

Cephalexin remains an effective antibiotic for many common infections, particularly those caused by susceptible gram-positive organisms, with the advantage of oral administration and generally good tolerability.

References

Guideline

Antibiotic Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cephalexin in the therapy of infections of the urinary tract.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.